By Pete Gallo
No, it hasn't been a promising season for investors in
medical stocks. That is unless you are talking about Perry
Capital and its growing portfolio of med stocks in the Far
East. Mind you, Perry isn't just dabbling in the sector. In
some instances, it's a dominant player. Filings with the
Securities and Exchange Commission show that as of early
February, Perry was the largest investor in China Medical
Technologies, a stock that has exploded in value over the past
Perry holds roughly a 12% stake in China Medical, some 3.3
million shares, based on February 14 filings with the SEC.
That's good news for Perry, as the stock has jumped from $21 a
share to $54 over the past six months. About $10 of that gain
came in January and early February, increasing Perry's stake to
$178.2 million - a profit of...